ClinicalTrials.gg
CompletedNCT07258498Updated Dec 2, 2025

Submucosal Dexamethasone for Control of Post-operative Pain, Trismus, and Swelling After Mandibular Third Molar Surgery

A Phase 4 interventional study of Dexamethasone and Normal Saline in Impacted Mandibular Third Molar Extraction, sponsored by PAEC General Hospital, Islamabad. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-12-02.

Sponsored by PAEC General Hospital, Islamabad · Phase 4, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Oct 2024, registered Nov 2025).
Phase
Phase 4
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

Purpose: The aim of this study is to determine the efficacy of submucosal injection of dexamethasone in reducing pain, swelling and trismus, thus to minimize patient's discomfort after surgery, so that the patients could pursue their daily activities without delay. Moreover, the submucosal injection is convenient to the patient and surgeon both, as it is injected after application of local anesthesia and easily administered. OBJECTIVES: To evaluate the outcome of submucosal injection of 4mg/ml dexamethasone in comparison with submucosal injection of normal saline (N/S) on mean post-operative pain, trismus and swelling following mandibular third molar surgery.

Read the detailed description

OPERATIONAL DEFINITIONS:

Pain: Post-operative pain outcome when measured using Visual Analogue Scale (VAS) would determine the subjective pain experience of patients. VAS is a straight, 10 cm long horizontal line. VAS represents continuous pain intensity, where the left end of the line indicates "no pain," while the right end denotes "worst pain imaginable." Patients indicate their level of pain (in cm) by marking a single point on the line.

Swelling: Post-operative facial swelling would be assessed by using Gabka and Matsumara technique. Linear distance between angle of the mandible to lateral corner of the eye (A), distance between tragus to corner of the mouth (B), and distance between tragus to soft tissue pogonion (C) would be quantified in millimeters using measuring tape. The sum of these measurements would be calculated as facial dimension and used to measure the level of swelling in millimeters.

Trismus: Trismus i.e., reduced mouth opening would be quantified in millimeters by measuring interincisal distance at maximum mouth opening using a vernier caliper. Normal mouth opening ranges from 40 to 60 mm. Mouth opening less than 40 mm is considered trismus.

HYPOTHESIS:

Submucosal injection of 4mg/ml dexamethasone will result in lower mean postoperative pain, reduced trismus and less swelling after mandibular third molar surgery.

02

Conditions studied

  • Impacted Mandibular Third Molar Extraction

Browse trials for

Keywords

  • submucosal dexamethasone
  • impacted mandibular third molar
  • surgical extraction
  • pain
  • swelling
  • trismus
03

In context

Pain

10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.

This study's enrollment of 70 is close to the median of 66 across 8,493 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

PAEC General Hospital, Islamabad is the lead sponsor of 9 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Cases of impacted mandibular third molar according to Pell and Gregory classification (class l, 2. 3 and A. B, C)
  • Both genders (male and female)
  • Age limit: 18 - 45 years

Exclusion criteria

Exclusion Criteria:

  • Patients with pericoronitis.
  • Patients with known allergy to .
  • Medically compromised patients.
  • Current pregnancy.
  • Lactating women.
  • Use of medication by the patients that could interfere with the healing process.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    Dexamethasone

    submucosal injection of dexamethasone would be used in this study to prevent post-operative pain , swelling and trismus in patient having surgical extraction of impacted mandibular third molars.

    Drug: Dexamethasone

  • Placebo comparator
    Normal saline (placebo)

    Out of 70 patients 35 patients would be given submucosal injection of normal saline as a placebo.

    Drug: Normal Saline

Interventions

  • In this study submucosal injection of dexamethasone would be given to the patient 30 minutes before surgical extraction of impacted mandibular third molar surgery to reduce pain, swelling and trismus, thus to minimize patient's discomfort after surgery, so that the patients could pursue their daily activities without delay

  • DrugNormal Saline

    submucosal injection of normal saline (N/S) would not reduce trismus, swelling, and pain

06

What researchers measure

Primary outcomes

  1. measurement of post-operative pain, in patients who have undergone surgery for impacted mandibular third molars.

    Pain: Post-operative pain outcome when measured using Visual Analogue Scale (VAS) would determine the subjective pain experience of patients. VAS is a straight, 10 cm long horizontal line. VAS represents continuous pain intensity, where the left end of the line indicates "no pain," while the right end denotes "worst pain imaginable." Patients indicate their level of pain (in cm). by marking a single point on the line.

    Time frame: from enrolment to 7th post operative day

  2. measurement of post-operative trismus in patients who have undergone surgery for impacted mandibular third molars.

    Trismus i.e., reduced mouth opening would be quantified in millimeters by measuring interincisal distance at maximum mouth opening using a vernier caliper. Normal mouth opening ranges from 40 to 60 mm. Mouth opening less than 40 mm is considered trismus.

    Time frame: From enrollment to the 7th Postoperative day

  3. measurement of post-operative swelling in patients who have undergone surgery for impacted mandibular third molars.

    Swelling: Post-operative facial swelling would be assessed by using Gabka and Matsumara technique. Linear distance between angle of the mandible to lateral corner of the eye (A), distance between tragus to corner of the mouth (B), and distance between tragus to soft tissue pogonion (C) would be quantified in millimeters using measuring tape. The sum of these measurements would be calculated as facial dimension and used to measure the level of swelling in millimeters.

    Time frame: from enrolment to 7th post operative day

Secondary outcomes

  1. demographic data (name, age, gender)

    name, age, gender would be used to assess the effects of demographic data on post operative sequelae

    Time frame: from enrolment to 7th post operative day

  2. tooth number of impacted tooth according to FDI tooth numbering system, type of impaction

    tooth number of impacted tooth according to FDI tooth numbering system, type of impaction according to pell and gregory classification would be used to assess any effect of these outcomes on post-operative sequelae after mandibular third molar surgery.

    Time frame: from enrolment to 7th post operative day

  3. No. of Paracetamol 500 mg tablets taken orally postoperatively

    No. of Paracetamol 500 mg tablets taken orally postoperatively would be used to assess if patient was pain free or had pain post-operatively following impacted mandibular third molar surgery.

    Time frame: from enrolment to 7th post operative day

07

Study locations

1 site
  • PAEC General Hospital, Islamabad
    Islamabad, Capital 44000, Pakistan
08

References and documents

Individual participant data

Plan to share: No — As the hospital where this study is being conducted does allow to share any collected data with other researchers due to patient confidentiality

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07258498
Lead sponsor
PAEC General Hospital, Islamabad
Responsible party
Kanza Ateeque (Postgraduate Trainee Dr Kanza Ateeque, PAEC General Hospital, Islamabad) — Principal investigator
First posted
Dec 2, 2025
Start date
Oct 1, 2024
Primary completion
Sep 30, 2025
Completion
Sep 30, 2025
Last update
Dec 2, 2025

Study contacts

Dr Kanza Ateeque, BDS
principal investigator · PAEC General Hospital, Islamabad

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Dexamethasone

Start the discussion